Reaction pattern to histamine and codeine in a human intradermal skin test model

Clinical and Experimental Allergy

Volumn 37, Issue 1, 2007, Pages 39-46

  Scherer, K ^b   Grize, L ^c   Schindler, C ^c   Surber, C ^b   Bircher, A J ^a,b  

^a Department of Dermatology   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

Author keywords

Codeine; Histamine; Intradermal skin tests; Weal size

Indexed keywords

ACETIC ACID DERIVATIVE; CODEINE; ETHYLENEDIAMINE; HISTAMINE; OPIATE RECEPTOR;

ADULT; ARM; ARTICLE; BLOOD VESSEL REACTIVITY; CALCULATION; CELL SURFACE; COMPARATIVE STUDY; COMPUTER PROGRAM; CONCENTRATION (PARAMETERS); FEMALE; FOREARM; HUMAN; HUMAN EXPERIMENT; MALE; MAST CELL; PRIORITY JOURNAL; REACTION ANALYSIS; SKIN MANIFESTATION; SKIN TEST; URTICARIA;

ADULT; ALLERGENS; ANALYSIS OF VARIANCE; BACK; CODEINE; DERMATITIS, ALLERGIC CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOREARM; HISTAMINE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRADERMAL; INTRADERMAL TESTS; MALE; PHOTOGRAPHY; SKIN; URTICARIA;

EID: 33845793884     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2006.02596.x     Document Type: Article

References (31)

1. Dolen WK. Skin testing techniques. In: Dolen WK, ed. Immunology and allergy clinics of North America. Philadelphia: WB Saunders, 2001; 273-79.
2. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57:45-51.
3. Bernstein IL, Storms WW. Practice parameters for allergy diagnostic test. Task Force on Practice Parameters for the Diagnosis and Treatment of Asthma. The American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1995; 75:543-2.
4. Barbaud A, Reichert-Penetrat S, Tréchot P et al. The use of skin testing in the investigation of cutaneous adverse drug reaction. Br J Dermatol 1998; 139:49-58.
5. Gomes ER, Pichler WJ, Demoly P, Aberer W, Frew AJ, deWeck A. for ACII and WHO. The drug ambassador project. The diversity of diagnostic procedures for drug allergy around Europe. Allergy Clin Immunol Int - J World Allergy Org 2005; 17:9-18.
6. Barbaud A, Trechot P, Reichert-Penetrat S, Commun N, Schmutz JL. Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions. Contact Dermatitis 2001; 45:265-8.
7. Warrington RJ, McPhilipps S. Independent anaphylaxis for cefazolin without allergy to other β-lactam antibiotics. J Allergy Clin Immunol 1996; 98:460-2.
8. Van Hage-Hamsten M, Pauli G. Provocation testing with recombinant allergens. Methods 2004; 32:281-91.
9. Gupta S, Jain S, Chaudhry S, Agarwal MK. Role of insects as inhalant allergens in bronchial asthma with special reference to the clinical characteristics of patients. Clin Exp Allergy 1990; 20:519-24.
10. Laxenaire MC, Mertes PM, Groupe d'Etudes. des Reactions Anaphylactoides Peranesthesiques. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth 2001; 87:549-58.
11. Dib S, Grimfeld A, Sahraoui F, Timsit S, Just J. Prevalence of latex sensitization in infants and young children with asthma. Rev Fr Allergol Immunol Clin 2001; 41:382-8.
12. Berg CM, Heier T, Wilhelmsen V, Florvaag E. Rocuronium and cisatracurium-positive skin tests in non-allergic volunteers: determination of drug concentration thresholds using a dilution titration technique. Acta Anaesthesiol Scand 2003; 47:576-582.
13. Turkeltaub PC, Rastogi SC, Baer H, Anderson MC, Norman PS. A standardized quantitative skin-test assay of allergen potency and stability: studies on the allergen dose-response curve and effect of wheal, erythema and patient selection on assay results. J Allergy Clin Immunol 1982; 70:343-52.
14. 50 EAL method (intradermal dilution for 50mm sum of erythema diameters determines the allergy unit). In: Brede HD, Göing H, Schaeffer M, eds Regulatory Control and Standardization. Fourth international Paul-Ehrlich Seminar. Arbeiten aus dem Paul-Ehrlich Institut, dem Georg-Speyer Haus und dem Ferdinand Blum Institut, Stuttgart. New York: Gustav Fisher-Verlag, 1987; 169-73.
15. Dreborg SKG. Skin testing in allergen standardization and research. In: Dolen WK, ed. Immunology and allergy clinics of North America. Philadelphia: WB Saunders, 2001; 329-54.
16. Olson R, Karpink MH, Shelanski S, Atkins PC, Zweiman B. Skin reactivity to codeine and histamine during prolonged corticosteroid therapy. J Allergy Clin Immunol 1990; 86:153-9.
17. Sussman GL, Harvey RP, Schocket AL. Evaluation of skin test response using two techniques of measurement. Ann Allergy 1982; 48:75-7.
18. Klimek L, Weber K, Mann W. Der Hauttest-Scanner (STS), ein Scanning-System zur Objektivierung von Hauttestreaktionen. Allergologie 1998; 21:527-33.
19. Niemeijer NR, Fluks AF, de Monchy JG. Optimization of skin testing, II: evaluation of concentration and cutoff values, as compared with RAST and clinical history, in a multicenter study. Allergy 1993; 48:498-503.
20. Jutel M, Scrbic D, Pichler WJ, Muller UR. Ultra-Rush bee venom immunotherapy does not reduce cutaneous weal responses to bee venom and codeine phosphate. Clin Exp Allergy 1995; 25:1205-10.
21. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized placebo-controlled trial. Clin Exp Allergy 2003; 33:1076-82.
22. Petersen LJ, Nielsen HJ, Skov PS. Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy 1995; 25:1045-52.
23. Nelson HS, Knoetzer J, Bucher B. Effect of distance between sites and region of the body on results of skin prick tests. J Allergy Clin Immunol 1996; 97:596-601.
24. Ronchetti R, Villa MP, Bohmerova Z et al. Skin reactivity to histamine and codeine in unselected 9-year old children from Italy, Poland and Libya. Int Arch Allergy Immunol 2004; 135:136-42.
25. Weber W, Knop J, Maurer M. Pattern analysis of human cutaneous mast cell populations by total body surface mapping. Br J Dermatol 2003; 148:224-228.
26. Casale TB, Bowman S, Kaliner M. Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: evidence for opiate and nonopiate receptor participation. J Allergy Clin Immunol 1984; 73:775-81.
27. Berther T, Conroy MC, De Weck AL. Urticarial skin reaction to codeine, a measure of mast cell reactivity. Schweiz med Wochenschr 1980; 110:758-63.
28. Goldberg A, Korzets Z, Bernheim J, Mekori Y. Cutaneous responses to histamine, compound 48/80 and codeine in patients with chronic renal failure. Ann Allergy 1991; 67:525-8.
29. Xu JH, Wang P, Chen ZG, Zhang JX. Influence of calcium concentration on 4-aminopyridine induced histamine release from isolated peritoneal mast cells. Yao Xue Xue Bao 1995; 30:235-8.
30. Riccardi D. Cell surface, Ca2+(cation)-sensing receptor(s): one or many? Cell Calcium 1999; 26:77-83.
31. Lu Y, Li L, Luo W. A study on the changes of calcium signal in mast cells activated by antigen. Zhonghua Jie He He Xi Za Zhi 2000; 23:243-6.